IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $271,000 | +44.9% | 5,248 | +17.1% | 0.00% | 0.0% |
| Q2 2018 | $187,000 | -5.6% | 4,483 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $198,000 | -15.0% | 4,483 | -3.3% | 0.00% | 0.0% |
| Q4 2017 | $233,000 | -13.1% | 4,634 | -12.3% | 0.00% | -25.0% |
| Q3 2017 | $268,000 | -5.0% | 5,285 | -4.5% | 0.00% | 0.0% |
| Q2 2017 | $282,000 | +17.0% | 5,535 | -7.8% | 0.00% | 0.0% |
| Q1 2017 | $241,000 | -16.0% | 6,002 | +0.0% | 0.00% | -33.3% |
| Q4 2016 | $287,000 | -78.9% | 6,000 | -83.8% | 0.01% | -75.0% |
| Q3 2016 | $1,359,000 | +66.7% | 37,100 | +6.0% | 0.02% | +50.0% |
| Q2 2016 | $815,000 | -63.1% | 35,000 | -35.8% | 0.02% | -62.8% |
| Q1 2016 | $2,207,000 | -53.1% | 54,500 | -28.3% | 0.04% | -47.6% |
| Q4 2015 | $4,710,000 | – | 76,060 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |